179 related articles for article (PubMed ID: 27203673)
1. Effect of nodal status on clinical outcomes of triple-negative breast cancer: a population-based study using the SEER 18 database.
Wang XX; Jiang YZ; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Jul; 7(29):46636-46645. PubMed ID: 27203673
[TBL] [Abstract][Full Text] [Related]
2. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
3. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer - A Cohort from China.
Yin L; Shuang H; Sheng C; Liang H; Sun XJ; Yang WT; Shao ZM
Sci Rep; 2018 Jun; 8(1):9007. PubMed ID: 29899402
[TBL] [Abstract][Full Text] [Related]
5. Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.
Hernandez-Aya LF; Chavez-Macgregor M; Lei X; Meric-Bernstam F; Buchholz TA; Hsu L; Sahin AA; Do KA; Valero V; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2011 Jul; 29(19):2628-34. PubMed ID: 21606433
[TBL] [Abstract][Full Text] [Related]
6. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
8. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
Rose BS; Jiang W; Punglia RS
Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
[TBL] [Abstract][Full Text] [Related]
9. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
Zhao S; Ma D; Xiao Y; Jiang YZ; Shao ZM
Eur J Surg Oncol; 2018 Apr; 44(4):420-428. PubMed ID: 29429597
[TBL] [Abstract][Full Text] [Related]
11. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
12. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.
Schmidt G; Meyberg-Solomayer G; Gerlinger C; Juhasz-Böss I; Herr D; Rody A; Liedtke C; Solomayer EF
Arch Gynecol Obstet; 2014 Dec; 290(6):1221-9. PubMed ID: 25012601
[TBL] [Abstract][Full Text] [Related]
14. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
15. The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
Zhang L; Tang R; Deng JP; Zhang WW; Lin HX; Wu SG; He ZY
BMC Cancer; 2020 Nov; 20(1):1146. PubMed ID: 33238939
[TBL] [Abstract][Full Text] [Related]
16. Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.
Chen L; Zhang J; Chen J; Liu L; Liang L; Shangguan Z; Wang D
Oncotarget; 2017 Jun; 8(26):42917-42925. PubMed ID: 28476034
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together?
Dai Kubicky C; Mongoue-Tchokote S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases.
Gangi A; Mirocha J; Leong T; Giuliano AE
Ann Surg Oncol; 2014 Dec; 21(13):4098-103. PubMed ID: 25155393
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
